Showing results (2101-2110 of 2,913) with videos related to

Sort By:
Pageof 292
Circulation|August 11, 2004
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Kidney International|May 20, 2004
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Trials|October 10, 2015
Physical activity screening to recruit inactive randomized controlled trial participants: how much is too much?Corneel Vandelanotte, Robert Stanton, Amanda L Rebar, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
M1 receptor agonist activity is not a requirement for muscarinic antinociceptionM J Sheardown, H E Shannon, M D Swedberg, et al.
Chemical Biology & Drug Design|December 19, 2008
Inhibitors of tubulin assembly identified through screening a compound libraryRachel E Morgan, Sunnoo Ahn, Sandra Nzimiro, et al.
The Journal of Experimental Medicine|September 14, 2016
Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processingTakanobu Tagawa, Manuel Albanese, Mickaël Bouvet, et al.
Scientific Reports|May 21, 2017
Radiopaque Resorbable Inferior Vena Cava Filter Infused with Gold NanoparticlesLi Tian, Patrick Lee, Burapol Singhana, et al.
Oxidative Medicine and Cellular Longevity|June 1, 2018
Heme Oxygenase-2 Localizes to Mitochondria and Regulates Hypoxic Responses in HepatocytesPaul K Waltz, Benjamin Kautza, Jason Luciano, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|May 8, 2002
Evaluation guidelines for adult and pediatric kidney transplant programs: the Missouri experienceWanda L Hillerman, Cynthia L Russell, Dana Barry, et al.
Lab on a Chip|September 19, 2025
Correction: A nanobody-based microfluidic chip for fast and automated purification of protein complexesPhebe De Keyser, Mitch de Waard, Ignaas S M Jimidar, et al.
Pageof 292